Objectives-Patients with hematologic malignancies, especially those with acute disease or those receiving intense chemotherapy, are known to develop acute acalculous cholecystitis (AAC). The aim of this study was to evaluate the diagnostic and prognostic value of the established ultrasound (US) diagnostic criteria for AAC in patients with acute hematologic malignancies who were clinically suspected to have AAC.
critically ill and in an advanced stage of disease and have higher rates of emergency department visits, hospitalization, and intensive care unit use. [6] [7] [8] Clinical diagnosis of AAC in these patients is difficult because clinical features such as right upper quadrant pain and fever may be attributable to other abdominal complications such as enterocolitis, and abnormal leukocyte counts can be caused by the underlying hematologic malignancy. Compared with calculous cholecystitis, AAC is associated with a higher rate of complications, with gangrene found in up to 50% and gallbladder perforation in up to 10% of cases on histologic examination. 5 Therefore, early diagnosis and intervention are imperative whenever AAC is clinically suspected in patients with advanced hematologic malignancies.
Imaging is used to support the clinical diagnosis of AAC. Ultrasound (US) is often the first modality used because it is easily accessible at the bedside, quick, relatively inexpensive, and repeatable. Ultrasound criteria commonly used for the diagnosis of AAC are gallbladder wall thickening, gallbladder distension of greater than 4 mm, pericholecystic fluid, sludge, a sloughed mucosal membrane, and intramural gas. 9 Different combinations of these findings have been used as criteria to diagnose AAC, with sensitivities ranging from 18% to 93%. 10, 11 Imhof et al 11 found that US morphologic changes were detected within 24 hours of symptom onset, and a triad of gallbladder hydrops, wall thickening, and sludge was detected by 11 days on average. Wang et al 12 used a scoring system and found a higher tendency for complications in patients with a higher score; however, this finding was not statistically significant. Cornwell et al 10 were able to preoperatively diagnose AAC in 13 of 14 patients using the major criteria of wall thickening, pericholecystic fluid, intramural gas, and a sloughed mucosal membrane and the minor criteria of distension and sludge. However, a few studies of critically ill patients have shown that some of these findings may be seen in patients without AAC. 13, 14 Thus, uncertainty exists about the diagnostic value of US criteria and their prognostic significance.
Although limited studies have documented AAC in patients with leukemia, 1, 4 to our knowledge, no study has specifically documented the prognostic importance of US criteria for AAC in patients with hematologic malignancies. A better understanding of what percentage of patients with similar right upper quadrant symptoms meet US criteria for AAC, along with the prognostic importance of these criteria, would improve clinical management and treatment plans.
Therefore, the purpose of our study was to evaluate the prognostic importance of US criteria for AAC in hospitalized patients with hematologic malignancies. We hypothesized that the presence of positive US criteria could predict a higher rate of complications and mortality. To test our hypothesis, we retrospectively studied US criteria for AAC in hospitalized patients with hematologic malignancies who had clinical findings suggestive of AAC (fever, right upper quadrant pain, abnormal liver function test results, and tenderness).
Materials and Methods
This Health Insurance Portability and Accountability Act-compliant retrospective study was approved by the University of Texas M. D. Anderson Cancer Center's Institutional Review Board with a waiver for informed consent. The study participants were identified through a search of the institutional radiology database for abdominal US studies performed for right upper quadrant symptoms in hospitalized patients with advanced hematologic malignancies (leukemia, lymphoma, and myeloma) from August 2011 to August 2016. We defined advanced hematologic malignancies as incurable diseases at presentation or recurrent diseases not eligible for potentially curative treatments per oncology notes. The search yielded 368 patients who were hospitalized with advanced hematologic malignancies and who had abdominal US examinations for right upper quadrant symptoms. Among these 368 patients, we excluded 124 patients who had gallbladder calculi, 58 patients who had calculus cholecystitis, 50 patients who had a history of cholecystectomy, 24 patients who had liver disease that could have contributed to right upper quadrant symptoms, and 14 patients who had more than 1 malignancy; another 4 patients were excluded because of limited US examinations of the gallbladder, which yielded inconclusive findings. In total, 94 consecutive patients who had advanced hematologic malignancies and were suspected to have AAC were included in the analysis. All of the patients had clinical features that were suspicious for AAC at the time of the US examinations. Specifically, all 94 patients had fever, abnormal liver function test results, right upper quadrant pain, and tenderness.
Ultrasound Protocol
All US studies were performed in a single institution on iU22 US machines (Philips Healthcare, Bothell, WA) using a curvilinear transducer (3) (4) (5) (6) (7) (8) . The studies were performed according to standardized US examination protocols by 6 certified sonographers with experience ranging from 1 to 30 years. Static images and cine loops of the gallbladder were recorded in longitudinal and transverse planes through intercostal, subcostal, and decubitus subcostal approaches. All of the images were reviewed by fellowship-trained abdominal radiologists while the patients were still in the department. The images were stored and reviewed on a standard picture archiving and communication system. Two abdominal radiologists with 1 and 5 years of experience, who were blinded to the original US reports, reviewed the gallbladder images in consensus on a picture archiving and communication system monitor and documented their findings. The gallbladders were evaluated for the presence of US criteria, 9 as shown in Table 1 . Ultrasound findings were considered positive for AAC if at least 2 major criteria or 1 major and 2 minor criteria were present. Ultrasound findings in a representative case are shown in Figure 1 .
We also reviewed these patients' electronic medical records and collected clinical data, which included age, sex, primary hematologic malignancy, and absolute neutrophil count. The clinical course over 3 months after the US examination from the initial time of clinical suspicion was reviewed for the duration of symptoms, treatment, complications, follow-up imaging tests, and outcome (mortality). Our analysis included only complications related to cholecystitis that were diagnosed on subsequent imaging tests or pathologic examinations; these included gallbladder perforation, pericholecystic abscesses, gallbladder hemorrhage, and septicemia due to cholecystitis.
Statistical Analysis
The patients were divided into 2 groups: patients with positive US findings for AAC and those with negative US findings for AAC. In the groups, the duration of symptoms and the rate of complications or gallbladderspecific mortality were compared. The Wilcoxon rank sum test was used to compare the duration of symptoms, and the Fisher exact test was used to compare complication rates in the groups. All statistical calculations were performed by using SPSS software for Macintosh, version 24.0 (IBM Corporation, Armonk, NY), and SAS software for Windows, version 9.4 (SAS Institute Inc, Cary, NC). Table 2 . Among the 94 patients, US showed abnormal gallbladder wall thickening in 66 (70%), pericholecystic fluid in 45 (48%), sloughed mucosa in 15 (16%), echogenic bile/sludge in 60 (64%), and gallbladder hydrops in 38 (40%). None of the US examinations showed intramural gas. Nine patients, all of whom were in the AAC-positive group, developed complications; these included 2 patients with gallbladder perforation, 3 with pericholecystic abscesses, and 4 with septicemia. None of the patients developed gallbladder hemorrhage ( Table  2) . We found no significant difference in the presence of any individual complication between the groups (Table  3) . However, a positive US diagnosis for AAC was associated with the occurrence of complications, which were seen in 9 (20.9%) of 43 patients in the positive group and none in the negative group (P 5 .0005; Table 3 ). Among the US features, the presence of pericholecystic fluid (8 of 45 patients; P 5 .01), echogenic bile/sludge (9 of 51 patients; P 5 .02), and gallbladder distention of greater than 4 cm (9 of 38 patients; P 5 .0002) were associated with the occurrence of complications (Table 4) . Sloughed mucosa was seen only in the positive group (15 of 43 patients), but only 1 patient with sloughed mucosa developed a complication (P > .99). Although 2 deaths occurred in the positive group, they were unrelated to gallbladder disease. In the negative group, 21 (41%) of the 51 patients had a diagnosis of AAC on follow-up diagnostic tests: 14 (27.4%) patients had positive findings on subsequent US examinations performed within 1 week, and 7 (13.7%) had positive findings on follow-up hepatobiliary scans performed within 1 week. Another 14 patients (27.4%) in the negative group continued to have negative findings on subsequent follow-up tests despite persistent right upper quadrant symptoms. None of the patients with a diagnosis of AAC on follow-up tests developed complications. Thirty-eight patients in the positive group underwent follow-up tests; of these, 13 (34%) patients continued to have positive findings on the follow-up tests. Of the 6 patients in the positive group who underwent follow-up US examinations within 1 week, 1 patient (2.6%) continued to have positive findings, and 5 (13%) had negative findings for AAC on the subsequent examinations (Table 5) .
Patients with positive AAC diagnoses based on US findings had a significantly longer duration of fever and right upper quadrant symptoms than those with negative diagnoses. Specifically, the mean durations of symptoms were 7.8 days in the positive group and 3.9 days in the negative group (P < .0001; Table 6 ). Complete resolution of fever and right upper quadrant symptoms with medical treatment occurred in 32 of the 43 patients in the positive group and in 45 of the 51 patients in the negative group. Cholecystostomy was required for 10 patients in the positive group and 4 patients in the negative group (Table 2 ).
Discussion
Our results indicate that patients with advanced hematologic malignancies and a diagnosis of AAC based on US criteria have a higher rate of complications and a longer duration of symptoms compared with patients who have negative US findings. In our study, the positive group had a complication rate of 20.9%. This higher rate was in concordance with complication rates in some previous studies. For example, studies have shown a higher incidence of complications such as gangrene and gallbladder perforation in AAC compared with calculous cholecystitis. 15 In a series of 445 patients with postoperative AAC, Inoue and Mishima 16 found a complication rate of 55% and a mortality rate of 23%. More recent studies have shown mortality rates ranging from 11% to 40%; the lower rates in some recent studies were likely due to a higher index of suspicion, improved imaging, and better treatment for AAC. [17] [18] [19] Previous studies attempted to find clinical or imaging features of AAC that predicted complications. Wang et al 12 found that a high white blood cell count and older age correlated with a higher incidence of complications. They used a US scoring system and found a trend toward a higher score in patients who later developed severe complications, although the trend was not statistically significant. 12 Although our study was not intended to find specific predictors of complications, positive US findings based on 2 major or 1 major and 2 minor criteria showed a significantly higher rate of complications. Interestingly, although gallbladder distension and sludge were considered minor criteria, all 9 patients in our study who developed complications had both of these findings. Other studies have shown that gallbladder sludge leads to subsequent complications such as cholecystitis, cholangitis, and pancreatitis; these symptoms can be prevented by cholecystectomy. 20, 21 Overdistention of the gallbladder (which was seen in all 9 patients who had complications in our study) and increased intraluminal pressure are believed to cause ischemia, potentially leading to complications such as gangrene and gallbladder perforation. 22 Many risk factors have been implicated in causing AAC, including recent surgery, critical illness requiring intensive care unit admission, burns, immunosuppression, and sepsis. 9 In patients with hematologic malignancies, abdominal infections are life threatening, especially during periods of neutropenia, with reported mortality rates of up to 26%. 3 In patients with hematologic malignancies, AAC is more common than calculous cholecystitis, and there is a high risk of sepsis. 3 Leukemic infiltration of the gallbladder can also cause cholecystitis and has been reported as a rare presenting manifestation of leukemia. 23 Surgery for acute abdominal pain in patients with hematologic malignancies is risky, with mortality rates of up to 55%. Although early laparoscopic cholecystectomy is considered safe in patients with AAC, 24 individualized management based on the prognosis and risk is recommended in patients with advanced malignancies and cholecystitis. 25 Another important feature of AAC is its rapidly progressive nature. Johnson 26 found that 40% of patients who underwent surgery 48 hours after the onset of symptoms had gallbladder perforation, whereas only 8% of those who underwent surgery earlier had perforation. In our study, 41% of the patients in the negative group were found to have positive findings for AAC on followup US or hepatobiliary scans within 1 week. This finding reflects the rapidly progressive nature of AAC. Still, these patients had a lower rate of complications and duration of symptoms. These patients might have had an early or milder presentation of AAC, resulting in initial negative US findings. Moreover, early diagnosis and treatment could explain the lower rate of complications and duration of symptoms in this group. These findings agree with the study by Jeffrey and Sommer, 27 who reported that 4 of 8 patients whose initial US findings were negative for AAC were found to have increased gallbladder wall thickness on follow-up US examinations performed within 24 hours. Because of the rapidly progressive nature of AAC, several authors have emphasized the importance of daily follow-up US studies to help early detection of progression and to avoid misdiagnosis. 11, 28 Hence, follow-up US in borderline cases will help reduce complications and mortality by facilitating early diagnosis and prompt treatment.
Some authors have shown that US findings of AAC are nonspecific and may be found in patients without AAC. Boland et al 13 found no significant correlation of US gallbladder abnormalities with clinical and laboratory parameters, but others have shown that when correlated with clinical features, US is the investigation of choice for AAC in critically ill patients. 9 Hence, diagnosis should not rely solely on US findings and should be correlated with clinical and laboratory parameters.
Our study had several limitations. Most importantly, it was a retrospective study based on search terms, with an inherent selection bias. Although it was possible to select a homogeneous group of hospitalized patients with a diagnosis of advanced hematologic malignancies, the patients received different treatments for their primary cancers. We only included patients with right upper quadrant pain who underwent right upper quadrant US examinations; it is possible that some patients who were not imaged or were imaged with other cross-sectional modalities were excluded, resulting in underestimation of complications. Also, the study was performed at a tertiary care cancer center. Thus, the generalizability of our findings in other settings is unclear. Acute acalculous cholecystitis was not pathologically proven most of the patients (78 of 94); however, such patients in the acute phase rarely undergo cholecystectomy in routine clinical practice because of their critical conditions and advanced malignancies. A significant number of patients with negative US findings (41%) had positive findings on followup studies; it would have been helpful to identify which US findings should prompt a follow-up imaging study, but our study did not find any statistically significant predictors. Finally, we did not assess the gallbladder for the resolution of US findings after treatment because our objective was to assess their prognostic importance.
In conclusion, patients with positive US criteria and a clinical suspicion of AAC should be treated aggressively because they are prone to have a higher complication rate and a longer duration of symptoms. In borderline cases, a follow-up US study allows early detection of AAC progression and prompt treatment to substantially reduce complications.
